Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases.

52W Range

52ndpctl

Volume

0.89×avg

Market Cap

2.97BUSD

P/E Ratio

107.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Arcutis Biotherapeutics, Inc.

ARQTNASDAQ Global Select·USD·Closed

Arcutis Biotherapeutics, Inc.

ARQTNASDAQ·USD·Closed

$23.78

−4.38%

$23.78

−$1.09 (4.38%)

52W Range

52ndpctl

Volume

0.89×avg

Mkt Cap

2.97BUSD

P/E

107.7TTM

Div Yield

–ann

ARQT: Arcutis Biotherapeutics, Inc. Stock Analysis | finqOS